Clinical applications of bone density testing for osteoporosis

Area of Science:

• Bone Densitometry
• Osteoporosis Diagnosis
• Fracture Risk Assessment

Background:

• Bone mineral density (BMD) testing is crucial for diagnosing osteoporosis and assessing fracture risk.
• Various non-invasive technologies measure BMD across different skeletal sites.
• Dual-energy X-ray absorptiometry (DXA) is the established gold-standard for osteoporosis diagnosis and BMD monitoring.

Purpose of the Study:

• To review the clinical applications of bone mineral density testing.
• To highlight the importance of optimal DXA use through standardized procedures and quality controls.
• To discuss the correlation between BMD T-scores and fracture risk, particularly in postmenopausal women.

Main Methods:

• Review of non-invasive BMD measurement technologies, focusing on DXA.
• Explanation of BMD classification (normal, osteopenia, osteoporosis) using T-scores.
• Integration of BMD testing with clinical risk factors for fracture prediction.

Main Results:

• BMD testing effectively diagnoses osteoporosis and monitors bone density changes.
• DXA requires rigorous quality control for accurate results.
• A strong correlation exists between T-scores and fracture risk in postmenopausal women.

Conclusions:

• BMD testing, especially DXA, is vital for osteoporosis management and fracture risk assessment.
• Standardized protocols and quality control are essential for reliable BMD testing.
• Combining BMD results with clinical risk factors optimizes patient management and therapeutic decisions.